TNFAIP3 mutation may be associated with favorable overall survival for patients with T-cell lymphoma.
Cunte ChenZheng ChenLing HuangLingling ZhouLihua ZhuSichu LiuGengxin LuoWenyu LiChengwu ZengYangqiu LiPublished in: Cancer cell international (2021)
To the best of our knowledge, we for the first time describe that TNFAIP3 mutations in non-CDS regions are associated with favorable OS for TCL patients, which might be a potential biomarker for the prognostic stratification of Chinese TCL patients.